Company intelligence / Profile preview

Geno Does It

Milwaukee, Wisconsin, United Statesgenodoesit.com ↗

Ownership: Private
Development stage: Commercial

Overview

Geno.Me operates a digital health platform that aggregates clinical, genetic, and genomic data from individuals who consent to share their deidentified information. The platform connects patients directly with researchers and organizations seeking real-world health datasets for medical research. Contributors are compensated each time their dataset is purchased. After beta testing in 2022 and privacy/security certifications in 2023, the product launched publicly in Q3 2023. The company targets pharmaceutical and clinical research industries for growth[4][6].

Modalities: Platform (health/genomic data aggregation and sharing)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Gateway Capital Partners (investor)

Beyond the preview

Go deeper on Geno Does It.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Geno Does It.

Explore the full profile